Cargando…
Galectin-14 promotes hepatocellular carcinoma tumor growth via enhancing heparan sulfate proteoglycan modification
Hepatocellular carcinoma (HCC) is a highly heterogeneous malignancy and lacks effective treatment. Bulk-sequencing of different gene transcripts by comparing HCC tissues and adjacent normal tissues provides some clues for investigating the mechanisms or identifying potential targets for tumor progre...
Autores principales: | Gou, Liming, Yang, Gang, Ma, Sujuan, Ding, Tong, Sun, Luan, Liu, Fang, Huang, Jin, Gao, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Department of Journal of Biomedical Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687530/ https://www.ncbi.nlm.nih.gov/pubmed/37977559 http://dx.doi.org/10.7555/JBR.37.20230085 |
Ejemplares similares
-
Heparan sulfate proteoglycans and their modification as promising anticancer targets in hepatocellular carcinoma
por: Alshehri, Mohammed A., et al.
Publicado: (2021) -
Heparan Sulfate and Heparan Sulfate Proteoglycans in Cancer Initiation and Progression
por: Nagarajan, Arvindhan, et al.
Publicado: (2018) -
Heparan sulfate proteoglycans and cancer
por: Blackhall, F H, et al.
Publicado: (2001) -
Heparan Sulfate Proteoglycans in Infection
por: Bartlett, Allison H., et al.
Publicado: (2011) -
Heparan Sulfate Proteoglycans in Tauopathy
por: Zhu, Yanan, et al.
Publicado: (2022)